tigrix 60 mg filmtabletten
tigrix 90 mg filmtabletten
smith & nephew bactigras wound dressing
smith & nephew pte. limited - general hospital - bactigras is for use as a topical treatment only. it is indicated for a wide range of wounds where there is a risk of infection, or on already infected wounds in conjunction with systemic antibacterial agents. the range of wounds on which bactigras may be used include: • minor burns and scalds • lacerations, abrasions and other skin loss wounds • donor and recipient graft sites
tigornicine 3gm granules in sachets
tigris pharma-egypt - sachet - 3 gm
xigris
eli lilly and company (nz) limited - drotrecogin alfa (activated) 20mg ([recombinant human acitvated protein c (rhapc)]) - powder for infusion - 20 mg - active: drotrecogin alfa (activated) 20mg ([recombinant human acitvated protein c (rhapc)]) excipient: hydrochloric acid citrate buffer (containing citrate, citric acid, hcl, naoh) hydrochloric acid sodium chloride sodium hydroxide sucrose water for injection
xigris
eli lilly and company (nz) limited - drotrecogin alfa (activated) 5mg ([recombinant human acitvated protein c (rhapc)]) - powder for infusion - 5 mg - active: drotrecogin alfa (activated) 5mg ([recombinant human acitvated protein c (rhapc)]) excipient: hydrochloric acid citrate buffer (containing citrate, citric acid, hcl, naoh) hydrochloric acid sodium chloride sodium hydroxide sucrose water for injection
xigris 5mg powder for solution for infusion vials
eli lilly and company ltd - drotrecogin alfa - powder for solution for infusion - 5mg
xigris 20mg powder for solution for infusion vials
eli lilly and company ltd - drotrecogin alfa - powder for solution for infusion - 20mg
xigris 20 mg powder
eli lilly (sa) (pty) ltd - powder - each vial contains drotrecogin alpha 20,0 mg